A case of Beh‡et's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab

被引：94
|
作者：
Hirano, Toru [1 ]
Ohguro, Nobuyuki [2 ]
Hohki, Satoshi [3 ]
Hagihara, Keisuke [1 ]
Shima, Yoshihito [1 ]
Narazaki, Masashi [1 ]
Ogata, Atsushi [1 ]
Yoshizaki, Kazuyuki [4 ]
Kumanogoh, Atsushi [1 ]
Kishimoto, Tadamitsu [5 ]
Tanaka, Toshio [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan
[2] Osaka Koseinenkin Hosp, Dept Ophthalmol, Osaka, Japan
[3] Toyama Univ, Dept Ophthalmol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan
[4] Osaka Univ, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan
[5] Osaka Univ, Lab Immune Regulat, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan
来源：
MODERN RHEUMATOLOGY | 2012年 / 22卷 / 02期
关键词：
Behcet's disease; IL-6; Tocilizumab; GENOME-WIDE ASSOCIATION; BEHCETS-DISEASE; CEREBROSPINAL-FLUID; INTERLEUKIN-6; IL23R-IL12RB2; GENERATION; THERAPY; CELLS; IL10;
D O I：
10.1007/s10165-011-0497-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 47-year-old female patient with Beh double dagger et's disease had been treated with colchicine, prednisolone, cyclosporine A, and infliximab. Because she relapsed, however, treatment with tocilizumab, a humanized anti-interleukin 6 receptor antibody, was started. This treatment suppressed the patient's clinical manifestations, including ocular attacks, for 1 year and improved her visual acuity. This experience indicates that tocilizumab may constitute a therapeutic option for refractory Beh double dagger et's disease.
引用
收藏
页码：298 / 302
页数：5
相关论文
共 50 条
  • [21] Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
    Koike, Ryuji
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Amano, Koichi
    Kawai, Shinichi
    Saito, Kazuyoshi
    Saito, Tomoyuki
    Yamamura, Masahiro
    Matsubara, Tsukasa
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2009, 19 (04) : 351 - 357
  • [22] Therapeutic efficacy of humanized anti-interleukin-6 receptor monoclonal antibody in renal involvement complicating Castleman's disease
    Kanai, Hidetoshi
    Hirano, Tadashi
    Arimura, Yosihide
    Yokota, Tadaaki
    Masutani, Kosuke
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 290 - 290
  • [23] Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
    Tanaka, Toshio
    Ogata, Atsushi
    Shima, Yoshihito
    Narazaki, Masashi
    Kumanogoh, Atsushi
    Kishimoto, Tadamitsu
    CURRENT RHEUMATOLOGY REVIEWS, 2012, 8 (03) : 209 - 226
  • [24] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis
    Uchiyama, Yasushi
    Yorozu, Keigo
    Hashizume, Misato
    Moriya, Yoichiro
    Mihara, Masahiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (06) : 1159 - 1163
  • [25] Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
    Okuda, Yasuaki
    Takasugi, Kiyoshi
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2997 - 3000
  • [26] Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia
    Ando, Katsutoshi
    Takahashi, Fumiyuki
    Motojima, Shinji
    Nakashima, Kei
    Kaneko, Norihiro
    Hoshi, Kazuei
    Takahashi, Kazuhisa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : E69 - E72
  • [27] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
    Hashizume, Misato
    Uchiyama, Yasushi
    Horai, Naoto
    Tomosugi, Naohisa
    Mihara, Masahiko
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (07) : 917 - 923
  • [28] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
    Misato Hashizume
    Yasushi Uchiyama
    Naoto Horai
    Naohisa Tomosugi
    Masahiko Mihara
    Rheumatology International, 2010, 30 : 917 - 923
  • [29] Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody
    Sugimoto, K
    Nishimoto, N
    Kishimoto, T
    Yoshizaki, K
    Nishimura, T
    ANNALS OF NUCLEAR MEDICINE, 2005, 19 (04) : 261 - 266
  • [30] Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody
    Kanji Sugimoto
    Norihiro Nishimoto
    Tadamitsu Kishimoto
    Kazuyuki Yoshizaki
    Tsunehiko Nishimura
    Annals of Nuclear Medicine, 2005, 19 : 261 - 266
12345